141 related articles for article (PubMed ID: 35342377)
1. Spanish Validation of the COMM Scale to Assess the Misuse of Prescription Opioids in Patients with Chronic Noncancer Pain.
Reyes-Pérez Á; López-Martínez AE; Esteve R; Ramírez-Maestre C
Int J Ment Health Addict; 2022 Mar; ():1-15. PubMed ID: 35342377
[TBL] [Abstract][Full Text] [Related]
2. Cross validation of the current opioid misuse measure to monitor chronic pain patients on opioid therapy.
Butler SF; Budman SH; Fanciullo GJ; Jamison RN
Clin J Pain; 2010; 26(9):770-6. PubMed ID: 20842012
[TBL] [Abstract][Full Text] [Related]
3. Adapting the Current Opioid Misuse Measure (COMM) for people with chronic pain and disability due to arthritis: The development of the COMM 11-PWDA.
Mallery Lankford C; Paez K; Yang M; Lin A
Disabil Health J; 2022 Jun; 15(2S):101296. PubMed ID: 35414483
[TBL] [Abstract][Full Text] [Related]
4. Development of a Brief Version of the Current Opioid Misuse Measure (COMM): The COMM-9.
McCaffrey SA; Black RA; Villapiano AJ; Jamison RN; Butler SF
Pain Med; 2019 Jan; 20(1):113-118. PubMed ID: 29237039
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and Predictive Capacity of the Spanish Versions of the Opioid Risk Tool and the Screener and Opioid Assessment for Patients with Pain-Revised: A Preliminary Investigation in a Sample of People with Noncancer Chronic Pain.
Esteve R; Reyes-Pérez Á; Ramírez-Maestre C; Gutiérrez-Extremera A; Fuentes-Bravo R; de la Vega R; Ruíz-Párraga GT; Serrano-Ibáñez ER; López-Martínez AE
Pain Ther; 2022 Jun; 11(2):493-510. PubMed ID: 35128624
[TBL] [Abstract][Full Text] [Related]
6. Psychometric Properties of the Spanish Version of the Pain Anxiety Symptoms Scale-20 (PASS-20-SV).
López-Martínez AE; Esteve R; Ruiz-Párraga GT; Rueda-Serrano C; Serrano-Ibáñez ER; Ramírez-Maestre C
Psicothema; 2021 May; 33(2):296-303. PubMed ID: 33879303
[TBL] [Abstract][Full Text] [Related]
7. The utility of a statewide prescription drug-monitoring database vs the Current Opioid Misuse Measure for identifying drug-aberrant behaviors in emergency department patients already on opioids.
Wilson MP; Cucciare MA; Porter A; Chalmers CE; Mullinax S; Mancino M; Oliveto AH
Am J Emerg Med; 2020 Mar; 38(3):503-507. PubMed ID: 31221474
[TBL] [Abstract][Full Text] [Related]
8. Identifying prescription opioid use disorder in primary care: diagnostic characteristics of the Current Opioid Misuse Measure (COMM).
Meltzer EC; Rybin D; Saitz R; Samet JH; Schwartz SL; Butler SF; Liebschutz JM
Pain; 2011 Feb; 152(2):397-402. PubMed ID: 21177035
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of the Current Opioid Misuse Measure.
Butler SF; Budman SH; Fernandez KC; Houle B; Benoit C; Katz N; Jamison RN
Pain; 2007 Jul; 130(1-2):144-56. PubMed ID: 17493754
[TBL] [Abstract][Full Text] [Related]
10. Translation and validation of the Chinese version of the Current Opioid Misuse Measure (COMM) for patients with chronic pain in Mainland China.
Zhao Y; Li Y; Zhang X; Lou F
Health Qual Life Outcomes; 2015 Sep; 13():147. PubMed ID: 26374505
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the current opioid misuse measure among substance use disorder treatment patients.
Ashrafioun L; Bohnert AS; Jannausch M; Ilgen MA
J Subst Abuse Treat; 2015 Aug; 55():15-20. PubMed ID: 25800105
[TBL] [Abstract][Full Text] [Related]
12. Exploring the Psychometric Properties of the Current Opioid Misuse Measure Among Adults With Chronic Pain and Opioid Use.
Rogers AH; Gallagher MW; Jamison RN; Zvolensky MJ
Clin J Pain; 2020 Aug; 36(8):578-583. PubMed ID: 32433073
[TBL] [Abstract][Full Text] [Related]
13. Detecting aberrant opioid behavior in the emergency department: a prospective study using the screener and Opioid Assessment for Patients with Pain-Revised (SOAPP
Varney SM; Perez CA; Araña AA; Carey KR; Ganem VJ; Zarzabal LA; Ramos RG; Bebarta VS
Intern Emerg Med; 2018 Dec; 13(8):1239-1247. PubMed ID: 29502329
[TBL] [Abstract][Full Text] [Related]
14. Transcultural validation of a French-European version of the Prescription Opioid Misuse Index Scale (POMI-5F).
Delage N; Cantagrel N; Delorme J; Pereira B; Dualé C; Bertin C; Chenaf C; Kerckhove N; Laporte C; Picard P; Roussin A; Authier N
Can J Anaesth; 2022 Aug; 69(8):1042-1052. PubMed ID: 35229249
[TBL] [Abstract][Full Text] [Related]
15. Should We Use COMM (Current Opioid Misuse Measure) to Screen for Opioid Abuse in Patients With Cancer Pain?
Moryl N; Mendoza TR; Horn SD; Eustaquio JC; Cleeland CS; Inturrisi C
J Natl Compr Canc Netw; 2023 Nov; 21(11):1132-1140.e3. PubMed ID: 37935105
[TBL] [Abstract][Full Text] [Related]
16. Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain.
Wasan AD; Butler SF; Budman SH; Benoit C; Fernandez K; Jamison RN
Clin J Pain; 2007 May; 23(4):307-15. PubMed ID: 17449991
[TBL] [Abstract][Full Text] [Related]
17. A multicenter, primary care-based, open-label study to identify behaviors related to prescription opioid misuse, abuse, and diversion in opioid-experienced patients with chronic moderate-to-severe pain.
Setnik B; Roland CL; Sommerville KW; Pixton GC; Berke R; Calkins A; Goli V
J Pain Res; 2015; 8():361-73. PubMed ID: 26185467
[TBL] [Abstract][Full Text] [Related]
18. Risk of opioid misuse in chronic non-cancer pain in primary care patients - a cross sectional study.
Just JM; Bingener L; Bleckwenn M; Schnakenberg R; Weckbecker K
BMC Fam Pract; 2018 Jun; 19(1):92. PubMed ID: 29925323
[TBL] [Abstract][Full Text] [Related]
19. A Rasch analysis of the Current Opioid Misuse Measure for patients with chronic pain.
Morris C; Green KE; Chimuma LL
J Opioid Manag; 2018; 14(1):9-14. PubMed ID: 29508891
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
